Follow
Boris Reva
Boris Reva
Computation Biology Center, Memorial Sloan-Kettering Cancer Center
Verified email at cbio.mskcc.org
Title
Cited by
Cited by
Year
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, ...
Cancer discovery 2 (5), 401-404, 2012
105592012
Comprehensive molecular portraits of human breast tumours
D Koboldt, R Fulton, M McLellan, H Schmidt, J Kalicki-Veizer, ...
Nature 490 (7418), 61-70, 2012
89632012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
CGAR Network
nature 455, 1061-8, 2008
63412008
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
59332012
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
56952011
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
Cell 155 (2), 462-477, 2013
38562013
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
35602010
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
34852013
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
30792012
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network
Nature 499 (7456), 43, 2013
22672013
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
21382014
Predicting the functional impact of protein mutations: application to cancer genomics
B Reva, Y Antipin, C Sander
Nucleic acids research 39 (17), e118-e118, 2011
17502011
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715-721, 2010
6962010
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ...
Nature genetics 43 (7), 668-672, 2011
6702011
p53 regulates hematopoietic stem cell quiescence
Y Liu, SE Elf, Y Miyata, G Sashida, Y Liu, G Huang, S Di Giandomenico, ...
Cell stem cell 4 (1), 37-48, 2009
5562009
A specificity map for the PDZ domain family
R Tonikian, Y Zhang, SL Sazinsky, B Currell, JH Yeh, B Reva, HA Held, ...
PLoS biology 6 (9), e239, 2008
5052008
EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics
ME Arcila, K Nafa, JE Chaft, N Rekhtman, C Lau, BA Reva, MF Zakowski, ...
Molecular cancer therapeutics 12 (2), 220-229, 2013
3372013
Characterization of HPV and host genome interactions in primary head and neck cancers
M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ...
Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014
3222014
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network
AA Hakimi, I Ostrovnaya, B Reva, N Schultz, YB Chen, M Gonen, H Liu, ...
Clinical Cancer Research 19 (12), 3259-3267, 2013
3162013
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2 (5): 401–404. doi: 10.1158/2159-8290
E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, ...
CD-12-0095.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
305
The system can't perform the operation now. Try again later.
Articles 1–20